
Keywords: AT-1; angiotensin II type 1; AT-2; angiotensin II type 2; BM; basement membrane; C/EBP3β; CCAAT/enhancer binding protein β; cSCC; cutaneous squamous cell carcinoma; EB; epidermolysis bullosa; ECM; extracellular matrix; DEB; dystrophic epidermolysis bull